- Home
- OPRA vs ZLAB Comparison
OPRA vs ZLAB Comparison
Compare OPRA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPRA | ZLAB |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | Norway | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.6B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OPRA | ZLAB |
|---|---|---|
| Price | $17.73 | $25.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $26.29 | ★ $33.14 |
| AVG Volume (30 Days) | 288.6K | ★ 698.4K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $20.36 | N/A |
| Revenue Next Year | $15.27 | $26.50 |
| P/E Ratio | $13.62 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $11.71 | $15.96 |
| 52 Week High | $20.78 | $34.07 |
Technical Indicators
Market Signals| Indicator | OPRA | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 58.51 |
| Support Level | $17.39 | $24.81 |
| Resistance Level | $19.43 | $27.20 |
| Average True Range (ATR) | 0.42 | 0.77 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 32.26 | 76.31 |
Price Performance
Historical ComparisonAbout OPRA Opera Limited
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.